Hinge Health (NYSE:HNGE) Stock Rating Upgraded by Wall Street Zen

Hinge Health (NYSE:HNGE) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research note issued to investors on Saturday.

A number of other research analysts have also recently weighed in on HNGE. Citizens Jmp assumed coverage on Hinge Health in a report on Monday, July 14th. They issued a “strong-buy” rating and a $58.00 target price on the stock. Barclays raised their price objective on Hinge Health from $62.00 to $65.00 and gave the stock an “overweight” rating in a report on Wednesday. KeyCorp increased their target price on shares of Hinge Health from $45.00 to $60.00 and gave the stock an “overweight” rating in a research report on Monday, July 14th. Stifel Nicolaus raised their price target on shares of Hinge Health from $63.00 to $66.00 and gave the company a “buy” rating in a report on Thursday, September 11th. Finally, Baird R W upgraded shares of Hinge Health to a “hold” rating in a research note on Friday, September 5th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $59.93.

Hinge Health Stock Up 0.9%

Hinge Health stock opened at $44.43 on Friday. Hinge Health has a 1 year low of $33.42 and a 1 year high of $62.18. The firm has a 50 day moving average of $52.43.

Hinge Health (NYSE:HNGE) last posted its quarterly earnings results on Tuesday, November 4th. The company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.20) by $0.18. The company had revenue of $154.21 million for the quarter, compared to analysts’ expectations of $142.44 million. The firm’s quarterly revenue was up 53.3% compared to the same quarter last year. Hinge Health has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS.

Institutional Trading of Hinge Health

Hedge funds have recently made changes to their positions in the company. Strategic Blueprint LLC acquired a new stake in Hinge Health during the 2nd quarter valued at $346,000. FNY Investment Advisers LLC purchased a new position in Hinge Health in the 2nd quarter valued at about $310,000. CHURCHILL MANAGEMENT Corp purchased a new position in Hinge Health in the 2nd quarter valued at about $828,000. Lisanti Capital Growth LLC acquired a new stake in shares of Hinge Health during the second quarter valued at about $3,089,000. Finally, Mark Sheptoff Financial Planning LLC purchased a new stake in shares of Hinge Health during the second quarter worth about $114,000.

About Hinge Health

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.